Dr. Adelyn Tu-Chan, DO

Dr. Tu-Chan practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Tu-Chan's NPI, 1720310329, was assigned on February 5, 2010. Dr. Tu-Chan graduated from Touro University California - Vallejo in 2007. Dr. Tu-Chan holds California license 1720310329.

Dr. Tu-Chan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Tu-Chan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Tu-Chan is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Tu-Chan to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tu-Chan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tu-Chan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tu-Chan is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Tu-Chan is licensed in California.

Dmand AI lists cerebrovascular disease, fibromyalgia and chronic pain, mobility impairment and thoracic spine disorders among the conditions Dr. Tu-Chan treats.

CMS data shows 604 Medicare services from Dr. Tu-Chan across 7 procedure codes in 2024, for 80 Medicare patients. Medicare paid $33,578 for them.

CMS counts 80 Medicare patients who saw Dr. Tu-Chan in 2024. The largest group is 65 to 74, with 36 patients. 65% of them have high cholesterol, and 60% have high blood pressure. 48% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tu-Chan's median patient age at 60, with 41% women.

In 2024, Dr. Tu-Chan wrote 66 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 55 of them, across 2 drugs with 11 or more claims each, at $1,166 in total drug cost. In 2023, CMS named 55 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Tu-Chan for performance year 2024, reported as part of a group. Dr. Tu-Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tu-Chan as offering telehealth.

Dmand AI links 17 papers to Dr. Tu-Chan, published from 2017 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Brain-Computer Interfaces, Speech and Tinnitus. Dr. Tu-Chan has published most often in J Neurointerv Surg. Dr. Tu-Chan's most frequent co-authors are Karunesh Ganguly, MD, PhD, Edward F. Chang, MD and Jessie Liu, MD.

CMS Open Payments shows 14 general payments to Dr. Tu-Chan from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 67% of the total. Medtronic USA, Inc. paid the most, $788.

Dr. Tu-Chan graduated from Touro University California - Vallejo in 2007.

Dr. Tu-Chan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.